{"transactions":[{"id":2986214,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-11-10T16:19:06.000Z","date":"2020-11-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on March 1, 2017."}],"balance_after":10000,"derivative":{"exercise_price":12.98,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-20-123596","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920123596/a4.xml","form_type":"4"}},{"id":2986213,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-10T16:19:06.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":5000,"price":25,"value":125000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020."}],"balance_after":44463,"source":{"system":"sec-edgar","filing":"0001104659-20-123596","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920123596/a4.xml","form_type":"4"}},{"id":2986212,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-10T16:19:06.000Z","date":"2020-11-09","kind":"exercise","acquired":true,"shares":5000,"price":12.98,"value":64900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020."}],"balance_after":49463,"source":{"system":"sec-edgar","filing":"0001104659-20-123596","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920123596/a4.xml","form_type":"4"}},{"id":2989498,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-11-06T17:43:48.000Z","date":"2020-11-05","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on March 1, 2017."}],"balance_after":15000,"derivative":{"exercise_price":12.98,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-20-122611","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920122611/a4.xml","form_type":"4"}},{"id":2989497,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, CFO"}}],"security":"Common Stock","published_at":"2020-11-06T17:43:48.000Z","date":"2020-11-05","kind":"sale","acquired":false,"shares":5000,"price":23,"value":115000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020."}],"balance_after":44463,"source":{"system":"sec-edgar","filing":"0001104659-20-122611","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920122611/a4.xml","form_type":"4"}},{"id":2989496,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, CFO"}}],"security":"Common Stock","published_at":"2020-11-06T17:43:48.000Z","date":"2020-11-05","kind":"exercise","acquired":true,"shares":5000,"price":12.98,"value":64900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020."}],"balance_after":49463,"source":{"system":"sec-edgar","filing":"0001104659-20-122611","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920122611/a4.xml","form_type":"4"}},{"id":3006096,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-10-15T18:04:19.000Z","date":"2020-10-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning on March 1, 2017."}],"balance_after":20000,"derivative":{"exercise_price":12.98,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-115378","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920115378/a4.xml","form_type":"4"}},{"id":3006095,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, CFO"}}],"security":"Common Stock","published_at":"2020-10-15T18:04:19.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":15000,"price":20.0338,"value":300507.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.0000 to $20.5000, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":44463,"source":{"system":"sec-edgar","filing":"0001104659-20-115378","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920115378/a4.xml","form_type":"4"}},{"id":3006094,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, CFO"}}],"security":"Common Stock","published_at":"2020-10-15T18:04:19.000Z","date":"2020-10-15","kind":"exercise","acquired":true,"shares":15000,"price":12.98,"value":194700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020."}],"balance_after":59463,"source":{"system":"sec-edgar","filing":"0001104659-20-115378","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920115378/a4.xml","form_type":"4"}},{"id":3044462,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-28T16:11:45.000Z","date":"2020-08-27","kind":"gift","acquired":false,"shares":1120,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44463,"source":{"system":"sec-edgar","filing":"0001104659-20-100179","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920100179/a4.xml","form_type":"4"}},{"id":3044461,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-28T16:11:45.000Z","date":"2020-08-25","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 526 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4."}],"balance_after":45583,"source":{"system":"sec-edgar","filing":"0001104659-20-100179","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920100179/a4.xml","form_type":"4"}},{"id":3140564,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-05-20T18:59:58.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning on March 1, 2017."}],"balance_after":35000,"derivative":{"exercise_price":12.98,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-064386","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920064386/a4.xml","form_type":"4"}},{"id":3140563,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-20T18:59:58.000Z","date":"2020-05-20","kind":"sale","acquired":false,"shares":15000,"price":25.0253,"value":375379.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.1700, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":46057,"source":{"system":"sec-edgar","filing":"0001104659-20-064386","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920064386/a4.xml","form_type":"4"}},{"id":3140562,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-20T18:59:58.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":15000,"price":12.98,"value":194700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019."}],"balance_after":61057,"source":{"system":"sec-edgar","filing":"0001104659-20-064386","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920064386/a4.xml","form_type":"4"}},{"id":3154131,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-05-11T18:42:59.000Z","date":"2020-05-08","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning on March 3, 2016."}],"balance_after":0,"derivative":{"exercise_price":9.13,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-059729","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920059729/a4.xml","form_type":"4"}},{"id":3154130,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-11T18:42:59.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":15000,"price":23.1356,"value":347034.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.0000 to $23.6700, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":46057,"source":{"system":"sec-edgar","filing":"0001104659-20-059729","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920059729/a4.xml","form_type":"4"}},{"id":3154129,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-11T18:42:59.000Z","date":"2020-05-08","kind":"exercise","acquired":true,"shares":15000,"price":9.13,"value":136950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 26, 2019."}],"balance_after":61057,"source":{"system":"sec-edgar","filing":"0001104659-20-059729","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920059729/a4.xml","form_type":"4"}},{"id":3248715,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP,Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-25T17:24:32.000Z","date":"2020-02-21","kind":"grant","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on February 21, 2021."}],"balance_after":50000,"derivative":{"exercise_price":23.99,"expiration_date":"2030-02-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-20-024847","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465920024847/a4.xml","form_type":"4"}},{"id":3450685,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP,Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-01T17:28:34.000Z","date":"2019-07-31","kind":"gift","acquired":false,"shares":2590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 376 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4."}],"balance_after":45682,"source":{"system":"sec-edgar","filing":"0001104659-19-043393","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465919043393/a4.xml","form_type":"4"}},{"id":3625866,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-28T16:29:32.000Z","date":"2019-02-27","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 28, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning on March 3, 2016."}],"balance_after":15000,"derivative":{"exercise_price":9.13,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-19-011559","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465919011559/a4.xml","form_type":"4"}},{"id":3625865,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-28T16:29:32.000Z","date":"2019-02-27","kind":"sale","acquired":false,"shares":20000,"price":41.5325,"value":830650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 28, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.0000 to $42.1900, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":47896,"source":{"system":"sec-edgar","filing":"0001104659-19-011559","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465919011559/a4.xml","form_type":"4"}},{"id":3625864,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-28T16:29:32.000Z","date":"2019-02-27","kind":"exercise","acquired":true,"shares":20000,"price":9.13,"value":182600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 28, 2018."}],"balance_after":67896,"source":{"system":"sec-edgar","filing":"0001104659-19-011559","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465919011559/a4.xml","form_type":"4"}},{"id":3631504,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP,Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-26T19:27:01.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 22, 2020."}],"balance_after":40000,"derivative":{"exercise_price":36.75,"expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-19-010799","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465919010799/a4.xml","form_type":"4"}},{"id":3631576,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-26T18:59:46.000Z","date":"2018-12-03","kind":"gift","acquired":false,"shares":8600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 521 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4."}],"balance_after":47896,"source":{"system":"sec-edgar","filing":"0001104659-19-010791","document":"a5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465919010791/a5.xml","form_type":"5"}},{"id":3874374,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-03T15:27:13.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted June 1, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in four equal annual installments beginning on March 3, 2016."}],"balance_after":35000,"derivative":{"exercise_price":9.13,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-18-043825","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918043825/a4.xml","form_type":"4"}},{"id":3874373,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-03T15:27:13.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted June 1, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning on January 21, 2015."}],"balance_after":0,"derivative":{"exercise_price":9.24,"expiration_date":"2024-01-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-18-043825","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918043825/a4.xml","form_type":"4"}},{"id":3874372,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-03T15:27:13.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":35000,"price":56.6261,"value":1981913.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted June 1, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.0000 to $58.5500, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":55975,"source":{"system":"sec-edgar","filing":"0001104659-18-043825","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918043825/a4.xml","form_type":"4"}},{"id":3874371,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-03T15:27:13.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":15000,"price":9.13,"value":136950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted June 1, 2018."}],"balance_after":90975,"source":{"system":"sec-edgar","filing":"0001104659-18-043825","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918043825/a4.xml","form_type":"4"}},{"id":3874370,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-03T15:27:13.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":20000,"price":9.24,"value":184800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted June 1, 2018."}],"balance_after":75975,"source":{"system":"sec-edgar","filing":"0001104659-18-043825","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918043825/a4.xml","form_type":"4"}},{"id":4051413,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-16T16:58:56.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 14, 2019."}],"balance_after":30000,"derivative":{"exercise_price":39.4,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-18-010414","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918010414/a4.xml","form_type":"4"}},{"id":4100322,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-12T16:32:48.000Z","date":"2018-01-11","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 12, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option became exercisable in four equal installments beginning on January 21, 2015, which was the first anniversary of the date on which the option was granted."}],"balance_after":20000,"derivative":{"exercise_price":9.24,"expiration_date":"2024-01-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-18-002075","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918002075/a4.xml","form_type":"4"}},{"id":4100321,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-12T16:32:48.000Z","date":"2018-01-11","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 12, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option became exercisable in four equal installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":7.9,"expiration_date":"2023-02-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-18-002075","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918002075/a4.xml","form_type":"4"}},{"id":4100320,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-12T16:32:48.000Z","date":"2018-01-11","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 12, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable in four equal installments beginning on December 30, 2012, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":5.88,"expiration_date":"2021-12-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-18-002075","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918002075/a4.xml","form_type":"4"}},{"id":4100319,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-12T16:32:48.000Z","date":"2018-01-11","kind":"sale","acquired":false,"shares":50000,"price":43.5629,"value":2178145.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 12, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.2500 to $43.8500, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":55975,"source":{"system":"sec-edgar","filing":"0001104659-18-002075","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918002075/a4.xml","form_type":"4"}},{"id":4100318,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-12T16:32:48.000Z","date":"2018-01-11","kind":"exercise","acquired":true,"shares":30000,"price":9.24,"value":277200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 12, 2017."}],"balance_after":105975,"source":{"system":"sec-edgar","filing":"0001104659-18-002075","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918002075/a4.xml","form_type":"4"}},{"id":4100317,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-12T16:32:48.000Z","date":"2018-01-11","kind":"exercise","acquired":true,"shares":20000,"price":7.9,"value":158000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 12, 2017."}],"balance_after":75975,"source":{"system":"sec-edgar","filing":"0001104659-18-002075","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918002075/a4.xml","form_type":"4"}},{"id":4100316,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-12T16:32:48.000Z","date":"2018-01-11","kind":"exercise","acquired":true,"shares":25000,"price":5.88,"value":147000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 12, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 259 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4."}],"balance_after":55975,"source":{"system":"sec-edgar","filing":"0001104659-18-002075","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465918002075/a4.xml","form_type":"4"}},{"id":4212638,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-08","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option became exercisable in four equal installments beginning on December 30, 2012, which was the first anniversary of the date on which the option was granted."}],"balance_after":25000,"derivative":{"exercise_price":5.88,"expiration_date":"2021-12-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4212637,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-08","kind":"exercise","acquired":false,"shares":23481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option became exercisable in four equal installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted."}],"balance_after":20000,"derivative":{"exercise_price":7.9,"expiration_date":"2023-02-05","underlying":"Common Stock","underlying_shares":23481},"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4212636,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-07","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option became exercisable in four equal installments beginning on December 30, 2012, which was the first anniversary of the date on which the option was granted."}],"balance_after":40000,"derivative":{"exercise_price":5.88,"expiration_date":"2021-12-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4212635,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-07","kind":"exercise","acquired":false,"shares":26519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option became exercisable in four equal installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted."}],"balance_after":43481,"derivative":{"exercise_price":7.9,"expiration_date":"2023-02-05","underlying":"Common Stock","underlying_shares":26519},"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4212634,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-08","kind":"exercise","acquired":true,"shares":15000,"price":5.88,"value":88200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."}],"balance_after":30716,"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4212633,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-08","kind":"sale","acquired":false,"shares":23481,"price":48.8891,"value":1147964.9571,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.6000 to $49.3500, inclusive. The reporting person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4."}],"balance_after":15716,"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4212632,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-08","kind":"exercise","acquired":true,"shares":23481,"price":7.9,"value":185499.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."}],"balance_after":39197,"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4212631,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-07","kind":"exercise","acquired":true,"shares":15000,"price":5.88,"value":88200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."}],"balance_after":15716,"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4212630,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-07","kind":"sale","acquired":false,"shares":1519,"price":48,"value":72912.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."}],"balance_after":716,"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4212629,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-07","kind":"sale","acquired":false,"shares":25000,"price":46.3561,"value":1158902.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.0000 to $47.3500, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":2235,"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4212628,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-09-11T19:23:27.000Z","date":"2017-09-07","kind":"exercise","acquired":true,"shares":26519,"price":7.9,"value":209500.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted August 8, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 495 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4."}],"balance_after":27235,"source":{"system":"sec-edgar","filing":"0001104659-17-056611","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917056611/a4.xml","form_type":"4"}},{"id":4344460,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-26T16:17:30.000Z","date":"2017-04-24","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 22, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option became exercisable in four equal installments beginning on December 30, 2012, which was the first anniversary of the date on which the option was granted."}],"balance_after":55000,"derivative":{"exercise_price":5.88,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-17-026371","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917026371/a4.xml","form_type":"4"}},{"id":4344459,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-26T16:17:30.000Z","date":"2017-04-24","kind":"sale","acquired":false,"shares":54000,"price":32.368,"value":1747872.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.2500 to $32.7500, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":221,"source":{"system":"sec-edgar","filing":"0001104659-17-026371","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917026371/a4.xml","form_type":"4"}},{"id":4344458,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-26T16:17:30.000Z","date":"2017-04-24","kind":"exercise","acquired":true,"shares":50000,"price":5.88,"value":294000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 22, 2017."}],"balance_after":54221,"source":{"system":"sec-edgar","filing":"0001104659-17-026371","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917026371/a4.xml","form_type":"4"}},{"id":4420964,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-27T21:58:26.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal installments beginning on February 24, 2018."}],"balance_after":50000,"derivative":{"exercise_price":25.3,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-17-012175","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465917012175/a4.xml","form_type":"4"}},{"id":4601328,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":145429,"kind":"person","name":"PATRICK GREGORY S","position":1,"cik":"0001219844","reported_name":"PATRICK GREGORY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-09-16T17:10:06.000Z","date":"2016-09-16","kind":"sale","acquired":false,"shares":2000,"price":25,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015, as amended May 9, 2016."}],"balance_after":3616,"source":{"system":"sec-edgar","filing":"0001104659-16-145199","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219844/000110465916145199/a4.xml","form_type":"4"}}]}